Japan’s Aug consumer inflation hits near 8-year high

Author of the article: Reuters Leika Kihara and Takahiko Wada TOKYO — Japan’s core consumer inflation quickened to 2.8% in August to hit the fastest annual pace in nearly eight years, data showed on Tuesday, a sign inflationary pressures from higher raw material costs and a weak yen were broadening. While core consumer inflation exceeded…
Japan’s Aug consumer inflation hits near 8-year high

Author of the article:

Reuters

Leika Kihara and Takahiko Wada

TOKYO — Japan’s core consumer inflation quickened to 2.8% in August to hit the fastest annual pace in nearly eight years, data showed on Tuesday, a sign inflationary pressures from higher raw material costs and a weak yen were broadening.

While core consumer inflation exceeded the central bank’s 2% target for five straight months, the Bank of Japan is unlikely to raise interest rates any time soon as wage and consumption growth remain weak, analysts say.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

The data highlights the dilemma the BOJ faces as it tries to underpin a fragile economy by maintaining ultra-low interest rates, which in turn is fueling an unwelcome slide in the yen that is driving up households’ cost of living.

The rise in the nationwide core consumer price index (CPI), which excludes volatile fresh food but includes fuel costs, was slightly bigger than a median market forecast for a 2.7% increase and followed a 2.4% gain in July.

Once welcomed for giving exports a boost, the yen’s weakness is becoming a headache for Japanese policymakers, because it hurts retailers and consumers by inflating the already rising prices of imported fuel and food.

The world’s third-largest economy expanded an annualized 3.5% in the second quarter, stronger than the preliminary estimate. But its recovery has been slower than many other countries as a resurgence in COVID-19 infections, supply constraints and rising raw material costs weighed on consumption and output.

While inflation is still modest compared with many other advanced nations, a global slowdown and high energy prices are clouding the outlook. The BOJ has pledged to keep interest rates ultra-low and remain an outlier in a global wave of monetary policy tightening. (Reporting by Leika Kihara and Takahiko Wada Editing by Kim Coghill & Shri Navaratnam)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Russia’s Rosneft Calls Seizure of Its German Unit Illegal
Read More

Russia’s Rosneft Calls Seizure of Its German Unit Illegal

(Bloomberg) -- Author of the article: Bloomberg News Bloomberg News Flammable gases released from a flare stack at the PCK Schwedt oil refinery, operated by PCK Raffinerie GmbH which is controlled by Rosneft Oil Co., in Schwedt, Germany, on Monday, May 9, 2022. A plan to ban Russian oil imports by the end of the…
US construction spending slips in February
Read More

US construction spending slips in February

Author of the article: Published Apr 03, 2023  •  1 minute read WASHINGTON — U.S. construction spending dipped in February as investment in single-family homebuilding maintained its downward trend amid higher mortgage costs. The Commerce Department said on Monday that construction spending slipped 0.1% in February after increasing 0.4% in January. Economists polled by Reuters…
U.S. FDA authorizes Bavarian Nordic’s vaccine for emergency use against monkeypox
Read More

U.S. FDA authorizes Bavarian Nordic’s vaccine for emergency use against monkeypox

Author of the article: The U.S. drug regulator on Tuesday authorized Bavarian Nordic’s Jynneos vaccine for emergency use through intradermal injection in individuals aged 18 years and older who are determined to be at high risk of monkeypox infection. The authorization from the Food and Drug Administration (FDA) will increase the total number of doses…